Literature DB >> 2887621

Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection.

A Pere, B Nowicki, H Saxén, A Siitonen, T K Korhonen.   

Abstract

In vivo expression, in human urine, of P, type-1, and type-1C fimbriae by Escherichia coli was analyzed by indirect immunofluorescence. Urine samples from 20 patients with acute urinary tract infection, as well as cultures of the corresponding E. coli isolates, were immunostained with three polyclonal antisera to P fimbriae, antiserum to type-1 fimbriae, monoclonal antibody specific for type-1C fimbriae, and fluorochrome-conjugated second antibodies. P fimbriae were found in 17 urine samples and in 18 of the isolated strains. Type-1-fimbriate bacteria were detected in only nine urine samples, although 18 of the isolated strains expressed type-1 fimbriae after growth in vitro. Four strains possessed type-1C fimbriae; only two expressed type-1C fimbriae in urine. The bacterial populations in urine were heterogeneous, and in each positive staining, only a fraction of the bacterial cells were reactive. The results show that E. coli P fimbriae are expressed and are subject to phase variation in vivo during acute urinary tract infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887621     DOI: 10.1093/infdis/156.4.567

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 2.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

Review 3.  Evolution of the chaperone/usher assembly pathway: fimbrial classification goes Greek.

Authors:  Sean-Paul Nuccio; Andreas J Bäumler
Journal:  Microbiol Mol Biol Rev       Date:  2007-12       Impact factor: 11.056

Review 4.  Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972.

Authors:  Per Klemm; Viktoria Hancock; Mark A Schembri
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

5.  Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins.

Authors:  J Parkkinen; R Virkola; T K Korhonen
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

6.  Binding characteristics of Escherichia coli adhesins in human urinary bladder.

Authors:  R Virkola; B Westerlund; H Holthöfer; J Parkkinen; M Kekomäki; T K Korhonen
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

7.  P-fimbriae vaccines. I. Cross reactive antibodies to heterologous P-fimbriae.

Authors:  M B Kaack; A Pere; T K Korhonen; S B Svenson; J A Roberts
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

8.  Role for FimH in Extraintestinal Pathogenic Escherichia coli Invasion and Translocation through the Intestinal Epithelium.

Authors:  Nina M Poole; Sabrina I Green; Anubama Rajan; Luz E Vela; Xi-Lei Zeng; Mary K Estes; Anthony W Maresso
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

9.  Coordinate gene regulation by fimbriae-induced signal transduction.

Authors:  M A Schembri; P Klemm
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

10.  Regulation of P-fimbrial phase variation frequencies in Escherichia coli CFT073.

Authors:  Nicola Holden; Makrina Totsika; Lynn Dixon; Kirsteen Catherwood; David L Gally
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.